Low-Dose Oral Minoxidil as Treatment for COVID-19 Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients

This study reported that micro-needling with Low-Level LED Therapy and Growth Factors may improve hair density in mild-to-moderate hair loss and telogen effluvium related to COVID-19, based on preliminary observations.

This review suggests that low-dose oral minoxidil may enhance hair density in certain nonandrogenetic alopecias, but highlights the need for controlled trials due to mixed and limited evidence.

This review article reports recent advancements in understanding, diagnosing, and treating various hair loss conditions, like androgenetic alopecia and alopecia areata, including their genetic factors and new therapeutic options, while also examining the impact of COVID-19 on hair loss.

In this observational study, researchers found that women with telogen effluvium who had higher baseline ferritin levels or received higher doses and longer durations of iron supplementation reported greater satisfaction, suggesting that iron supplementation can improve patient satisfaction regardless of initial ferritin levels.

This article confirms a significant rise in hair and scalp-related disorders at tertiary outpatient dermatology centers, particularly in cases of androgenetic alopecia and frontal fibrosing alopecia.